Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could disrupt India's pharma industry, leading to higher prices and reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results